Comprehensive Statistical Exploration of Prognostic (Bio-)Markers for Responses to Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer.

Cancers (Basel) · 2021 · PMC8750624 · PMID 35008239

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

weakly significantno p-value reported

In addition, in several of our analyses we found only weakly significant p -values close to 0.05 before multiple-testing adjustment.

also in 1,387 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.